Disclosed here are systems and methods for collecting and/or screening of a pancreatic secretion, using a capsule endoscope comprising an imaging system and a trypsin sensor, and a tether coupled to the capsule endoscope.

A system and method for display of subcutaneous cardiac monitoring data are provided. Cutaneous action potentials of a patient and other sensed data associated with the patient are recorded as electrocardiogram (EGC) data over a set time period using a subcutaneous insertable cardiac monitor. A set of R-wave peaks is identified within the ECG data and an R-R interval plot is constructed. A difference between recording times of successive pairs of the R-wave peaks in the set is determined. A heart rate associated with each difference is also determined. The pairs of the R-wave peaks and associated heart rate are plotted as the R-R interval plot. A diagnosis of cardiac disorder is facilitated based on patterns of the plotted pairs of the R-wave peaks, the associated heart rates in the R-R interval plot, and background data based on the other sensed data.

The present invention relates to a body monitoring system comprising a patch, the patch comprising a main body, the main body comprising a second face suitable for facing the skin of a user, the patch comprising an adhesive layer at least partially covering the second face, and a peelable cover covering the adhesive layer, the peelable cover comprising at least two separate portions, the portions being adjacent to each other, the main body and the adhesive layer comprise a central portion forming an opening suitable for receiving the capsule, the opening having a maximum diameter greater than 2 mm, preferably greater than 5 mm.

This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an immunosuppressant.

An implantable intravascular pressure sensor comprising a first transducer arranged to provide a pressure dependent signal in response to alternating electrical signals of a first frequency band, a second transducer arranged to provide a reference signal in response to alternating electrical signals of a second frequency band different from the first frequency band and an antenna coupling for sending and receiving said signals.

A patient monitoring and/or treatment system and method is disclosed. The system includes a wearable device configured to be wearable on an external portion of a patient. The wearable device configured to monitor and/or treat a biological feature of the patient, the wearable device including: one or more ultrasonic transmitters that provide ultrasonic energy to a monitoring site and/or a treatment site of the patient; one or more ultrasonic receivers that receive reflected ultrasonic energy from the monitoring site and/or the treatment site; and a controller that controls the one or more ultrasonic transmitter and the one or more ultrasonic receivers and determines an attribute of the biological feature based on the ultrasonic energy that is provided and the ultrasonic energy that is received.

A housing for a livestock sensor, the housing including: a resin having a coefficient of kinetic friction of 0.40 or lower and a coefficient of static friction of 0.10 or lower, and the resin being other than polytetrafluoroethylene. Also disclosed is a livestock sensor including the housing and a detector inside the housing.

An ingestible device for sampling material at least one time is provided. The ingestible device includes a first chamber that is enlargeable in volume and that includes an inlet, and that can be filled with the material to be sampled, a second chamber that is diminishable in volume and that includes an outlet, and a reversible actuating mechanism. The reversible actuating mechanism is configured such that triggering the reversible actuating mechanism leads to an enlargement of the first chamber to collect the material to be sampled through the inlet and also leads to a diminishment of the second chamber.

Gastric resident electronics, devices, systems, and related methods are generally provided. Some embodiments comprise administering (e.g., orally) an (electronic) resident structure to a subject (e.g., a patient) such that the (electronic) resident structure is retained at a location internal to the subject for a particular amount of time (e.g., at least about 24 hours) before exiting said location internal to the subject. In some embodiments, the resident structure is a gastric resident electronic. That is to say, in some embodiments, the resident structure is configured for relatively long gastric residence and comprises an electronic component. In some embodiments, the structures and components described herein may comprise one or more components configured for the delivery of an active substance(s) (e.g., a pharmaceutical agent) to the subject. In some embodiments, the device has a modular design, combining an electronic component(s) with materials configured for controlled and/or tunable degradation/dissolution to determine the time at which (gastric) residence is lost and the device exits the location internal to the subject. For example, in some embodiments, the resident structure comprises an electronic component and one or more additional components associated with the electronic component such that the resident structure is configured to be retained at a location internal to a subject for greater than or equal to 24 hours.

An apparatus that includes a partial power source including a first material and a second material, the partial power source configured to generate, upon contact with a conducting medium, a potential difference between the first material and the second material to provide power to a control device, and generate, using the first material and the second material, a current flow within the conducting medium, the current flow including information encoded based on a variable conductance between the first material and the second material.